Literature DB >> 18997760

Enforcing pharmaceutical and biotech patent rights in China.

Y Philip Zhang1, Michelle M Deng.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18997760     DOI： 10.1038/nbt1108-1235

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.

Authors:  Rahim Rezaie; Anita M McGahan; Sarah E Frew; Abdallah S Daar; Peter A Singer
Journal:  Health Res Policy Syst       Date:  2012-06-06

2.  Public funding and private investment for R&D: a survey in China's pharmaceutical industry.

Authors:  Lan Qiu; Zi-Ya Chen; Deng-Yu Lu; Hao Hu; Yi-Tao Wang
Journal:  Health Res Policy Syst       Date:  2014-06-13

3.  Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.

Authors:  Yun-Zhen Shi; Hao Hu; Chunming Wang
Journal:  Global Health       Date:  2014-11-19       Impact factor: 4.185

4.  Obstacles and opportunities in Chinese pharmaceutical innovation.

Authors:  Jingyun Ni; Junrui Zhao; Carolina Oi Lam Ung; Yuanjia Hu; Hao Hu; Yitao Wang
Journal:  Global Health       Date:  2017-03-24       Impact factor: 4.185
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.